Current data on methamphetamine;Données actuelles sur la méthamphétamine

Revue du Praticien

Volumn 62, Issue 5, 2012, Pages 679-681

  Cottencin, Olivier ^a,b   Rolland, Benjamin ^a,b   Guardia, Dewi ^a,b   Karila, Laurent ^c,d  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; NALTREXONE;

ACUTE PSYCHOSIS; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DEPRESSION; DRUG ABUSE; HUMAN; LUNG DISEASE; METHAMPHETAMINE DEPENDENCE; NEUROTOXICITY; PSYCHOTHERAPY; SHORT SURVEY; SUICIDAL BEHAVIOR; TOOTH DISEASE;

CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; METHAMPHETAMINE; STREET DRUGS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 84862195343     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Karila L, Petit A, Cottencin O, Reynaud M. Dépendance à la méthamphétamine: de nombreuses conséquences et complications. Presse Med 2010;39:1246-53.
2. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction 2009;104:1085-99.
3. Greene SL, Kerr F, Braitberg G. Review article: amphetamines and related drugs of abuse. Emerg Med Australas 2008;20:391-402.
4. Rendell PG, Mazur M, Henry JD. Prospective memory impairment in former users of methamphetamine. Psychopharmacology (Bert) 2009;203:609-16.
5. McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006;101:1473-8. (Pubitemid 44337772)
6. Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol 2010;69:578-92.
7. Jayaram-Lindstrom N, Hammarberg A, Beck O, Franck J. Naltrexone for the treatment of amphetamine dependence: a randomized placebo-controlled trial. Am J Psychiatry 2008;165:1442-8.
8. Shoptaw S, Heinzerling KG, Rotheram-Fuller E, et al. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend 2008;96:222-32.
9. Shearer J, Darke S, Rodgers C, et al. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction 2009;104:224-33.